Treatment and prevention of intestinal parasite-associated disease

Veterinary Clinics of North America - Equine Practice

Volumn 19, Issue 3, 2003, Pages 791-806

  Love, Sandy ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; CODEINE PHOSPHATE; FENBENDAZOLE; IVERMECTIN; MACROLIDE; MEBENDAZOLE; MOXIDECTIN; OXFENDAZOLE; OXIBENDAZOLE; PIPERAZINE; PRAZIQUANTEL; PREDNISOLONE; PYRANTEL EMBONATE; PYRANTEL TARTRATE; PYRIMIDINE; TIABENDAZOLE;

CESTODE; DIARRHEA; ENTEROPATHY; EVIDENCE BASED MEDICINE; INTESTINE PARASITE; NONHUMAN; PARASITE CONTROL; REVIEW; VALIDATION PROCESS; ANIMAL; ANIMAL DISEASE; DOSE RESPONSE; DRUG COMBINATION; DRUG RESISTANCE; HORSE; HORSE DISEASE; INTESTINE INFECTION;

CESTODA; EQUIDAE; EQUUS CABALLUS;

ANIMALS; ANTHELMINTICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HORSE DISEASES; HORSES; INTESTINAL DISEASES, PARASITIC; STRONGYLE INFECTIONS, EQUINE;

EID: 1842435218     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2003.08.003     Document Type: Review

References (55)

1. Drudge J.H., Szanto T., Wyant A.M. Critical tests of thiabendazole as an anthelmintic in the horse. Am J Vet Res. 35:1963;1409-1412
2. Cornwell R.L., Jones R.M. Field trials in horses with pyrantel tartrate. Vet Rec. 82:1968;586-587
3. Di Pietro J.A., Todd K.S., Lock T.F., McPherron T.A. Anthelmintic efficacy of ivermectin given intramuscularly in horses. Am J Vet Res. 43:1982;145-148
4. Lyons E.T., Tolliver S.C., Drudge J.H., Granstrom D.E., Collins S.S., Stamper S. Critical and controlled tests of activity of moxidectin (CL301,423) against natural infections of internal parasites of equids. Vet Parasitol. 41:1992;255-284
5. Love S., Murphy D., Mellor D. Pathogenicity of cyathostome infection. Vet Parasitol. 85:1999;113-122
6. Proudman C.J., French N.P., Trees A.J. Tapeworm infection as a significant risk factor for spasmodic colic and ileal impaction colic in the horse. Equine Vet J. 30:1998;194-199
7. Drudge J.H., Lyons E.T. Large strongyles: recent advances. Vet Clin North Am Equine Pract. 2:(2):1986;263-280
8. Lyons E.T., Tolliver S.C., Drudge J.H. Historical perspective of cyathostome: prevalence, treatment and control programs. Vet Parasitol. 85:1999;113-122
9. Sangster N.C. Pharmacology of anthelmintic resistance in cyathostomes: will it occur with the avermectin millbemycins. Vet Parasitol. 85:1999;189-204
10. Uhlinger C., Johnstone C. Failure to re-establish benzimidazole susceptible populations of small strongyles after prolonged treatment with non-benzimidazole drugs. Equine Vet Sci. 4:1984;7-9
11. Hennesy D. Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds. Vet Parasitol. 72:1997;367-390
12. Martin R.J. Modes of action of anthelmintic drugs. Vet J. 154:1997;11-34
13. Lanusse C., Prichard R. Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics. Vet Parasitol. 49:1993;123-158
14. McKellar Q.A., Benchaoui H.A. Avermectins and millbemycins. J Vet Pharmacol Ther. 19:1996;331-351
15. 13C labeled moxidectin in horses. J Agric Food Chem. 45:1997;3627-3633
16. Jacobs D.E., Huchinson M.J., Gibbons L.M. Equine cyathostome infection: suppression of faecal egg output with moxidectin. Vet Rec. 137:1995;545
17. Taylor S.M., Kenny J. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg count in horses. Vet Rec. 137:1995;516-518
18. Di Pietro JA, Hutchens DE, Lock TF, Walker K, Pual AJ, Shipley C, et al. Effect of moxidectin oral gel on post-treatment strongyle egg count suppression in horses. In: Proceedings of the American Association of Veterinary Parasitologists 41st Annual Meeting. Louisville; 1996.
19. Demeulenaere D., Vercryusse J., Dorny P., Claerebout E. Comparative studies of ivermectin and moxidectin in the control of naturally acquired cyathostome infections in horses. Vet Rec. 141:2001;383-386
20. Klei T.R., Chapman M.R., French D.D., et al. Evaluation of ivermectin at an evaluated dose against encysted equine cyathostome larvae. Vet Parasitol. 47:1993;99-106
21. Johnson P.J., Mrad D.R., Shwartz A.T., Kellam L. Presumed moxidectin toxicosis in three foals. J Am Vet Med Assoc. 214:1999;678-680
22. Prichard R.K., Hennesy D.R., Steel J.W. Prolonged administration: a new concept for increasing the spectrum of effectiveness of anthelmintics. Vet Parasitol. 1978;239-251
23. McKellar Q.A., Scott E.W. The benzimidazole anthelmintic agents - a review. J Vet Pharmacol Ther. 13:1990;223-247
24. Duncan J.L., McBeath D.G., Preston N.K. Studies on the efficacy of fenbendazole used in a divided dosage regime against strongyle infection in ponies. Equine Vet J. 12:1980;78-80
25. Duncan J.L., Bairden K., Abbott E.M. Elimination of muscosal cyathostome larvae by five daily treatments with fenbendazole. Vet Rec. 142:1998;268-271
26. Lyons E.T., Drudge J.H., Tolliver S.C., Swerczek T.W. Pyrantel pamoate: evaluating its activity against equine tapeworms. Vet Med. 81:1986;280-285
27. Britt D.P., Clarkson M.J. Experimental chemotherapy in horses infected with benzimidazole-resistant small strongyles. Vet Rec. 123:1988;219-221
28. Drudge J.H., Lyons E.T., Tolliver S.C., et al. Piperazine resistance in population - B equine strongyles: a study of selection in Thoroughbreds in Kentucky from 1966 through 1983. Am J Vet Res. 49:1988;986-994
29. Pereira M.C., Kohek I. Jr., Campos R., et al. A field evaluation of anthelmintics for control of cyathostomes of horses in Brazil. Vet Parasitol. 38:1991;121-129
30. Mercier P., Chick B., Alves-Branco, White C.R. Comparative efficacy, persistent effect, and treatment intervals of anthelmintic pastes in naturally infected horses. Vet Parasitol. 99:2001;29-39
31. Coles G.C., Hillyer M.H., Taylor F.G.R., Villard I. Efficacy of an ivermectin-praziquantel combination in equids against bots and tapeworms. Vet Rec. 152:2003;178-179
32. Lyons E.T., Tolliver S.C., Drudge J.H. Activity of praziquantel against Anoplocephala perfoliata (cestode) in horses. J Helminthol Soc (Washington). 59:1992;1-4
33. Reid S.W.J., Mair T.S., Hillyer M.H., Love S. Epidemiological risk factors associated with a diagnosis of clinical cyathostomiasis in the horse. Equine Vet J. 27:1995;127-130
34. Gibson T.E. The effect of repeated anthelmintic treatment with phenothiazine on the faecal egg counts of housed horses with some observations on the life cycle of Trichonema spp. in the horse. J Helminthol. 27:1953;29-40
35. Smith H.J. Strongyle infections in ponies I. Response to intermittent thiabendazole treatments. Can J Comp Med. 40:1976;327-333
36. Love S., McKeand J.B. 1998 Clinical cyathostomosis: practical aspects of treatment and prevention. Equine Vet Educ. 9:(5):1998;253-256
37. Love S. The role of equine strongyles in the pathogenesis of colic and current options for prophylaxis. Equine Vet J Suppl. 13:1992;5-9
38. Morris D.D., Crowe N., Johnson K., Moore J.N. Association of signalment and management factors with causes for colic in horses. Proc Am Assoc Equine Pract. 38:1992;441-454
39. Reeves M.J., Salman M.D., Smith G. Risk factors for equine acute abdominal disease (colic): results from a multicenter case-control study. Prev Vet Med. 26:1996;285-301
40. Tinker M.K., White N.A., Lessard P., Thatcher C.D., Pelzer K.D., Davis B., et al. Prospective study of equine colic risk factors. Equine Vet J. 29:1997;454-458
41. Cohen N.D., Gibbs P.G., Woods A.M. Dietary and other management factors associated with colic in horses. J Am Vet Med Assoc. 215:1999;53-60
42. Hillyer M.H., Taylor F.R., Proudman C.J., Edwards G.B., Smith J.E., French N.P. Case-control study to identify risk factors for simple colonic obstruction and distention colic in horses. Equine Vet J. 34:2002;455-463
43. Herd R.P. Epidemiology and control of equine strongylosis at Newmarket. Equine Vet J. 18:1986;447-452
44. Larsen M., Nansen P., Grøndahl C., Thamsborg S.M., Grønvold J., Wolstrup J., et al. The capacity of the fungus Duddingtonia flagrans to prevent strongyle infections in foals on pasture. Parasitology. 113:1996;1-6
45. Ihler C.F., Bjorn H. Use of two in-vitro methods for detection of benzimidazole resistance in equine small strongyles. Vet Parasitol. 65:1996;117-125
46. Craven J., Bjorn H., Barnes E.H., et al. A comparison of in vitro tests and a faecal egg count reduction test in detecting anthelmintic resistance in horse strongyles. Vet Parasitol. 85:1999;49-59
47. Pook J.F., Power M.L., Sangster N.C., Hodgson J.L., Hodgson D.R. Evaluation of tests for anthelmintic resistance in cyathostomes. Vet Parasitol. 106:2002;331-343
48. von Samson-Himmelstjerna G., von Witzendorff C., Sievers G., Schneider T. Comparative use of faecal egg count reduction test, egg hatch assay and beta-tubulin codon 200 genotyping in small strongyles (cyathostominae) before and after benzimidazole treatment. Vet Parasitol. 108:2002;227-235
49. Herd R.P., Gabel A.A. Reduced efficacy of anthelmintics in young compared with adult horses. Equine Vet J. 2:1990;164-169
50. Herd R.P., Majewski G.A. Comparison of daily and monthly pyrantel treatment in yearling thoroughbreds and the protective effect of strategic medication of mares on their foals. Vet Parasitol. 55:1994;93-104
51. Herd R.P., Coles G.C. Slowing the spread of anthelmintic resistant nematodes of horses in United Kingdom. Vet Rec. 136:1995;481-485
52. Proudman C.J., Matthews J.B. Control of intestinal parasites in horses. In Practice. 22:2000;90-97
53. Lloyd S., Smith J., Connan R.M., et al. Parasite control methods used by horse owners: factors predisposing to the development of anthelmintic resistance in nematodes. Vet Rec. 146:2000;487-492
54. Uhlinger C. Effects of three anthelmintic schedules on the incidence of colic in horses. Equine Vet J. 22:1990;251-254
55. Proudman C.J., Holdstock N.B. Investigation of an outbreak of tapeworm-associated colic in a training yard. Equine Vet J Suppl. 32:2000;37-41